In conclusion, CDK5 knockdown as a treatment and prevention appears to be a reasonable target based on taupathology and behavioral effects in 3xTg-AD mice, and suggest to be safety to the long term in both disease and control conditions, presenting the CDK5miR as a potential translation gene therapy. Here, CDK5 is linked to Alzheimer disease.